Value and access communications
Accurately and clearly communicating complex data
Written by experts. Valued by decision-makers.
As the leader in AMCP Format formulary dossier development, we apply a keen understanding of the reimbursement and formulary decision-making process, including knowledge of key influencers, primary drivers, and dossier utilization metrics to clearly convey your most complex data. Our team of highly respected and experienced team possess advanced clinical backgrounds, training in effective scientific communication, and strong familiarity with other US-based formulary templates, including the WellPoint Outcomes-Based Formulary guidelines and the Drug Effectiveness Review Project (DERP) evidence submission protocol.
Global Value Dossiers
We possess a deep knowledge of the access and reimbursement decision-making processes across major global markets, and understand the critical drivers and influencers that vary from country to country. With Xcenda, you will build a global value dossier that that tells your product or technology’s story in a clear and compelling way that will support local markets in preparing their own submissions. Trust in Xcenda’s 25+ year history of creating the industry’s most respected dossiers for key decision making bodies.
Enhance the way you visualize data. Optimize your SLR ROI. Create a usable and actionable resource.
Tame the “paper monster” of systematic literature reviews
Transform your approach to systematic literature reviews with Xcenda’s new digital platform, MetaMap Pro. And benefit from a tool your HEOR teams will actually want to use.
See what we mean when we say MetaMap Pro helps you “tame the paper monster!”
Communicate your value through credible publications.
Benefit from our 20+ year history, an unparalleled level of scientific expertise, and the ground-up creation of hundreds of evidence dossiers, economic models, peer-reviewed posters and publications for hundreds of products and technologies. With well over 50 published manuscripts in peer-reviewed journals and more than 700 poster presentations and symposia at national conferences, turn to the experts in publication planning and execution. View our featured publications.
Systematic Literature Review Evaluating Quality Assessment Tools
Sarah Cadarette, Luc Douyon, Padma Ranganathan, Nicholas Ballew, Jennifer Colby, Brett Maiese, Samantha Slaff, Erika Wissinger, Kimberly Ruiz
A comparison of health technology (HTA) requirements for systematic literature reviews (SLRs)
Evelyn Sarnes, Sarah Cadarette, Bethany Sawchyn, Kimberly Gittings, Werner Kulp, Eric Siu, Kimberly Ruiz, Erika Wissinger
Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison
Anne-Kathrin Claes, Werner Kulp
Oncology expertise to support market access for life-saving therapies
Conquering the Oncology Marketspace
Since 2006, our experience speaks volumes:
Meet the experts
Evelyn Sarnes, PharmD, MPH
Start a conversation
We’re value drivers and problem solvers. Let us connect you with experts who understand your world and what success demands.